Quality of life and treatment satisfaction in patients with hypothyroidism by McMillan, CV & Bradley, Clare
 1 
McMillan CV, Bradley C, Razvi S and Weaver JU (2005) Quality of life and treatment satisfaction in 
patients with hypothyroidism. Proceedings of the British Psychological Society 13 (1) 83. 
 
Poster presented at the British Psychological Society Division of Health Psychology Annual Conference, 
8-10th September 2004, Edinburgh. 
 
ABSTRACT FORM  
 
Authors & 
Affiliation. 
CV MCMILLAN, C BRADLEY, Royal Holloway, University of London; S RAZVI, 
Queen Elizabeth Hospital, Gateshead; JU WEAVER, University of Newcastle upon 
Tyne. 
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Content. Background: Hypothyroidism, a life-long chronic disease that slows the metabolism, is 
particularly prevalent in women and the elderly.  Treatment satisfaction and the impact of 
the condition on quality of life (QoL) were investigated. 
Methods: Semi-structured interviews were conducted with 38 patients with 
hypothyroidism (30 women and 8 men, mean age 51.9 (29 – 79) years, 37 treated with 
thyroxine) at three UK centres. The prime purpose of the interviews was to determine 
item selection for two new condition-specific questionnaires measuring QoL and 
treatment satisfaction. Open questions concerned the effects of underactive thyroid and 
its treatment on QoL, with interviewees being asked to imagine life without the disorder, 
(to elicit life domains impacted by hypothyroidism), and to comment aloud whilst 
completing draft questionnaires. Interview data were analysed for content. 
Findings: Patients described the negative impact of underactive thyroid on a number of 
life domains, particularly on energy, weight, physical appearance, physical capabilities, 
and motivation.  The great majority reported on-going negative impact on some aspects 
of life despite thyroxine treatment. Several patients (24%) expressed concerns about 
receiving sub-optimal thyroxine replacement that did not relieve lingering symptoms, and 
there was much dissatisfaction with lack of information provided by healthcare 
professionals about the condition and its treatment, particularly at diagnosis.  
Discussion: Multiple aversive symptoms remain despite thyroxine treatment, causing 
considerable dissatisfaction and marked impairment of QoL in many patients. Condition-
specific measures of QoL and treatment satisfaction were designed for use in evaluating 
and improving treatment for people with hypothyroidism and are now under development. 
 
 
 
